EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSCHYG00000013642
Gene Symbol: PSMD14
1 Cross references
213 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 3

Ensembl ID : ENSCHYG00000003352
Gene Symbol: PSMD3
1 Cross references
94 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSCHYG00000016855
Gene Symbol: PSMD6
1 Cross references
212 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSCHYG00000016390
Gene Symbol: PSMB11
1 Cross references
228 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSCHYG00000017109
Gene Symbol: PRMT5
1 Cross references
199 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSCHYG00000019829
Gene Symbol: PRKCA
1 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSCHYG00000001783
Gene Symbol: PRKCB
1 Cross references
299 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSCHYG00000022290
Gene Symbol: PRKCD
1 Cross references
283 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSCHYG00000016844
Gene Symbol: PRKCE
1 Cross references
326 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSCHYG00000009973
Gene Symbol: PRKCH
1 Cross references
241 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSCHYG00000006965
Gene Symbol: PRKCG
1 Cross references
200 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSCHYG00000009667
Gene Symbol: PRKCI
1 Cross references
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).